Report cover image

Canada Contrast Media Market Size, Share, & Trends Analysis Report: By Modality, By Product, By Application, By Route of Administration, By End Use (Hospital, Private Clinics, and Others) – Market Forecast, 2025–2034

Publisher Polaris Market Research & Consulting LLP
Published May 01, 2025
Length 125 Pages
SKU # PLRS20077197

Description

The canada contrast media market size is expected to reach USD 375.31 million by 2034, according to a new study by Polaris Market Research. The report “Canada Contrast Media Market Size, Share, & Industry Analysis Report: By Modality, By Product, By Application, By Route of Administration, By End Use (Hospital, Private Clinics, and Others) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Contrast media are substances used in medical imaging to enhance the visibility of internal structures such as blood vessels, organs, or tissues on scans such as X-rays, CTs, and MRIs.

Canada’s universal healthcare system ensures that all residents have access to medically necessary services, including diagnostic imaging. This broad access allows more people to undergo MRI and CT scans without worrying about high out-of-pocket costs. Since these scans often require contrast media to be effective, the public healthcare system helps maintain a strong demand for these products. The system also supports equal access across regions, ensuring that both large hospitals and smaller community clinics use contrast agents, contributing to the growth of the Canada contrast media market.

Canada is home to several leading research institutions and universities that actively collaborate with the medical imaging and pharmaceutical industries. These partnerships lead to innovations in contrast agent technology, such as safer formulations or agents tailored for specific imaging needs. Canadian companies and academic centers are further involved in clinical trials and product development, helping bring new solutions to the market. These technological advancements contribute to market growth by encouraging the use of newer products as they improve and become more widely adopted, thereby driving market growth.

Canada Contrast Media Market Report Highlights

In 2024, the iodinated segment dominated the Canada contrast media market due to its widespread use in CT scans, which are among the most commonly performed diagnostic imaging procedures in Canada.

The ultrasound segment is expected to witness the fastest growth during the forecast period, driven by the increasing use of contrast-enhanced ultrasound (CEUS) for real-time imaging of organs.

A few global key market players are Bayer AG, GE HealthCare, Guerbet, Lantheus, Bracco, Voyageur Pharmaceuticals Ltd, Grupo Juste, Franz Köhler Chemie GmbH, and MEDTRON AG.

Polaris Market Research has segmented the Canada contrast media market report on the basis of modality, product, application, route of administration, and end use:

By Modality (Revenue USD Million, 2020–2034)

Ultrasound

Magnetic Resonance Imaging

X-ray/Computed Tomography

By Product (Revenue USD Million, 2020–2034)

Microbubble

Gadolinium-Based

Iodinated

Iodixanol

Iohexol

Iopamidol

Others

Barium-Based

By Application (Revenue USD Million, 2020–2034)

Cardiovascular Disorders

Neurological Disorders

Gastrointestinal Disorders

Cancer

Nephrological Disorders

Musculoskeletal Disorders

Others

By Route of Administration (Revenue USD Million, 2020–2034)

Intravenous

Oral Route

Rectal Route

By End Use (Revenue USD Million, 2020–2034)

Hospitals

Private Clinics

Others

Table of Contents

125 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Canada Contrast Media Market Insights
4.1. Canada Contrast Media Market – Market Snapshot
4.2. Canada Contrast Media Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Elderly Population
4.2.1.2. Rising Cases of Chronic Disease
4.2.2. Restraints and Challenges
4.2.2.1. High Initial Investment
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Canada Contrast Media Market Trends
4.6. Value Chain Analysis
5. Canada Contrast Media Market, by Modality
5.1. Key Findings
5.2. Introduction
5.2.1. Canada Contrast Media Market, by Modality, 2020-2034 (USD million)
5.3. Ultrasound
5.3.1. Canada Contrast Media Market, by Ultrasound, 2020–2034 (USD million)
5.4. Magnetic Resonance Imaging
5.4.1. Canada Contrast Media Market, by Magnetic Resonance Imaging, 2020–2034 (USD million)
5.5. X-ray/Computed Tomography
5.5.1. Canada Contrast Media Market, by X-ray/Computed Tomography, 2020–2034 (USD million)
6. Canada Contrast Media Market, by Product
6.1. Key Findings
6.2. Introduction
6.2.1. Canada Contrast Media Market, by Product, 2020-2034 (USD million)
6.3. Microbubble
6.3.1. Canada Contrast Media Market, by Microbubble, 2020–2034 (USD million)
6.4. Gadolinium-Based
6.4.1. Canada Contrast Media Market, by Gadolinium-Based, 2020–2034 (USD million)
6.5. Iodinated
6.5.1. Canada Contrast Media Market, by Iodinated, 2020–2034 (USD million)
6.5.2. Iodixanol
6.5.2.1. Canada Contrast Media Market, by Iodixanol, 2020–2034 (USD million)
6.5.3. Iohexol
6.5.3.1. Canada Contrast Media Market, by Iohexol, 2020–2034 (USD million)
6.5.4. Iopamidol
6.5.4.1. Canada Contrast Media Market, by Iopamidol, 2020–2034 (USD million)
6.5.5. Others
6.5.5.1. Canada Contrast Media Market, by Others, 2020–2034 (USD million)
6.6. Barium-Based
6.6.1. Canada Contrast Media Market, by Barium-Based, 2020–2034 (USD million)
7. Canada Contrast Media Market, by Application
7.1. Key Findings
7.2. Introduction
7.2.1. Canada Contrast Media Market, by Medical Biotechnology, 2020-2034 (USD million)
7.3. Cardiovascular Disorders
7.3.1. Canada Contrast Media Market, by Cardiovascular Disorders, 2020–2034 (USD million)
7.4. Neurological Disorders
7.4.1. Canada Contrast Media Market, by Neurological Disorders, 2020–2034 (USD million)
7.5. Gastrointestinal Disorders
7.5.1. Canada Contrast Media Market, by Gastrointestinal Disorders, 2020–2034 (USD million)
7.6. Cancer
7.6.1. Canada Contrast Media Market, by Cancer, 2020–2034 (USD million)
7.7. Nephrological Disorders
7.7.1. Canada Contrast Media Market, by Nephrological Disorders, 2020–2034 (USD million)
7.8. Musculoskeletal Disorders
7.8.1. Canada Contrast Media Market, by Musculoskeletal Disorders, 2020–2034 (USD million)
7.9. Others
7.9.1. Canada Contrast Media Market, by Others, 2020–2034 (USD million)
8. Canada Contrast Media Market, by Route of Administration
8.1. Key Findings
8.2. Introduction
8.2.1. Canada Contrast Media Market, by Route of Administration, 2020-2034 (USD million)
8.3. Intravenous
8.3.1. Canada Contrast Media Market, by Intravenous, 2020–2034 (USD million)
8.4. Oral Route
8.4.1. Canada Contrast Media Market, by Oral Route, 2020–2034 (USD million)
8.5. Rectal Route
8.5.1. Canada Contrast Media Market, by Rectal Route, 2020–2034 (USD million)
9. Canada Contrast Media Market, by End Use
9.1. Key Findings
9.2. Introduction
9.2.1. Canada Contrast Media Market, by Route of Administration, 2020-2034 (USD million)
9.3. Hospitals
9.3.1. Canada Contrast Media Market, by Hospitals, 2020–2034 (USD million)
9.4. Private Clinics
9.4.1. Canada Contrast Media Market, by Private Clinics, 2020–2034 (USD million)
9.5. Others
9.5.1. Canada Contrast Media Market, by Private Clinics, 2020–2034 (USD million)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Bayer AG
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Bracco
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Dr. Franz Köhler Chemie GmbH
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. GE HealthCare
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. Grupo Juste
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. Guerbet
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Lantheus
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. MEDTRON AG
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Voyageur Pharmaceuticals Ltd
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us